English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/94031
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia

AutorSoriano, Sirena; Llorens, José V. ; Blanco-Sobero, Laura; Gutiérrez, Lucía ; Calap-Quintana, Pablo; Morales, M. P. ; Moltó, María D.; Martínez-Sebastián, María J.
Palabras claveClimbing capability
Life span
Oxidative stress
Mitochondria
Aconitase
Frataxin
Fecha de publicación2013
EditorElsevier
CitaciónGene 521(2): 274-281 (2013)
ResumenFriedreich's ataxia (FRDA), the most common inherited ataxia, is a neurodegenerative disease caused by a reduction in the levels of the mitochondrial protein frataxin, the function of which remains a controversial matter. Several therapeutic approaches are being developed to increase frataxin expression and reduce the intramitochondrial iron aggregates and oxidative damage found in this disease. In this study, we tested separately the response of a Drosophila RNAi model of FRDA ( Llorens et al., 2007) to treatment with the iron chelator deferiprone (DFP) and the antioxidant idebenone (IDE), which are both in clinical trials. The FRDA flies have a shortened life span and impaired motor coordination, and these phenotypes are more pronounced in oxidative stress conditions. In addition, under hyperoxia, the activity of the mitochondrial enzyme aconitase is strongly reduced in the FRDA flies. This study reports that DFP and IDE improve the life span and motor ability of frataxin-depleted flies. We show that DFP eliminates the excess of labile iron in the mitochondria and thus prevents the toxicity induced by iron accumulation. IDE treatment rescues aconitase activity in hyperoxic conditions. These results validate the use of our Drosophila model of FRDA to screen for therapeutic molecules to treat this disease.
URIhttp://hdl.handle.net/10261/94031
DOI10.1016/j.gene.2013.02.049
Identificadoresdoi: 10.1016/j.gene.2013.02.049
issn: 0378-1119
e-issn: 1879-0038
Aparece en las colecciones: (IBV) Artículos
(ICMM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.